Crescent Biopharma (CBIO) EPS (Basic) (2013 - 2026)
Crescent Biopharma (CBIO) reported EPS (Basic) of -$0.84 for Q1 2026, down 2011.11% year-over-year from $0.04 in Q1 2025, and up 74.26% quarter-over-quarter from -$3.28 in Q4 2025.
Crescent Biopharma (CBIO) EPS (Basic) (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 14 years of EPS (Basic) data on file, last reported at -$0.84 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.84, down 2011.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.46 (down 1522.73% YoY), and the FY2025 annual result was -$5.59, down 846.84% from the prior year.
- EPS (Basic) climbed to -$0.84 in Q1 2026 per CBIO's latest filing, from -$3.28 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.04 in Q1 2025 and troughed at -$3.28 in Q4 2025.
- A 5-year average of -$0.56 and a median of -$0.17 in 2023 frame the typical range for EPS (Basic).
- On a YoY basis, EPS (Basic) climbed as much as 76.47% in 2025 and fell as far as 2882.17% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.19 in 2022, then climbed by 26.32% to -$0.14 in 2023, then gained by 21.43% to -$0.11 in 2024, then slumped by 2882.17% to -$3.28 in 2025, then surged by 74.26% to -$0.84 in 2026.
- Business Quant data shows CBIO's EPS (Basic) at -$0.84 in Q1 2026, -$3.28 in Q4 2025, and -$1.77 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | -0.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.84 |
| Dec 31, 2025 | -3.28 |
| Sep 30, 2025 | -1.77 |
| Jun 30, 2025 | -1.57 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -0.13 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.19 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.33 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.28 |